CGEM | Complete Cullinan Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
手机东方财富网是东方财富网的手机门户网站,为亿万用户打造一个手机联通世界的超级平台,提供7*24小时全面及时的财经中文资讯,内容覆盖国内外突发事件、股市资讯、全球新闻、产业资讯、实用信息等。手机东方财富网触屏版 - eastmoney.com
Find the latest CGEM stock news. View the Cullinan Management news and quotes for today, invesment news based on TipRanks market-leading research tools.
韦德布什分析师Robert Driscoll维持$Cullinan Therapeutics(CGEM.US)$买入评级,维持目标价36美元。根据TipRanks数据显示,该分析师近一年总胜率为40.2%,总平均回报率为4.7%。提示: TipRanks为独立第三方,提供金融分析师的分析数据,并计算分析师推荐的平均回报率和胜率。提供的信息并非投资建议,仅供参考。本文不对评级数据...
Capital IQ调查的分析师表示,库里南肿瘤学(CGEM)的平均买入评级和目标股价在19美元至34美元之间。价格:18.1,涨幅:+0.39,变动百分比:+2.2 MT Newswires02/15 07:21 根据美国证券交易委员会最近的一份文件,库里南肿瘤内幕人士出售了价值647,200美元的股票 2024年2月1日,首席商务官科琳·萨维尔以647,200美元的价格...
百度股市通提供Cullinan Therapeutics, Inc.(CGEM)的行情报价、新闻资讯、股评、财报等信息,让用户在复杂的金融市场,更简单的获取投资信息。
Cullinan Therapeutics Inc. advanced stock charts by MarketWatch. View CGEM historial stock data and compare to other stocks and exchanges.
Get Cullinan Therapeutics Inc (CGEM:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.
Wedbush:重申Cullinan Therapeutics(CGEM.US)评级,由优于大市调整至优于大市评级, 目标价由36.00美元调整至36.00美元。 Cullinan Oncology(CGEM.US)公司简介:Cullinan Management Inc是一家生物制药公司。它专注于开发针对癌症和免疫肿瘤的靶向肿瘤和免疫肿瘤疗法的多元化渠道。
Management’s response and the steps they take to minimise any associated risks, forms an important part of Capital Group's assessment of management quality, which itself is a key factor in the stock selection decisions. Designated reference benchmark The Fund has not designated a reference bench...